These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 5396216)
1. [Personal experiences with myotonolytics]. Vurdelja N; Orovcanec K Med Pregl; 1969; 22(5-6):263-6. PubMed ID: 5396216 [No Abstract] [Full Text] [Related]
2. Utilization of the myorelaxant action of mydocalm in the clinical practice. Perényi G Ther Hung; 1978; 26(3):107-10. PubMed ID: 725813 [No Abstract] [Full Text] [Related]
3. [Status of the therapy of multiple sclerosis]. Bas H Ther Ggw; 1967 Oct; 106(10):1319-25. PubMed ID: 4314784 [No Abstract] [Full Text] [Related]
4. Arterio-venous disorders influenced centrally with Mydocalm. Fric M; Kozák P; Martinek J; Wimmer P Ther Hung; 1974; 22(3):108-11. PubMed ID: 4445978 [No Abstract] [Full Text] [Related]
6. [The effect of Mydeton on the psychic activity in cases of mental retardation]. Schwabik J; Péterfai J Orv Hetil; 1967 Jan; 108(4):157-60. PubMed ID: 6047454 [No Abstract] [Full Text] [Related]
7. Polymyositis with myotonia in a patient with common variable immunodefi ciency. Li Y; Zhang W; Feng LQ; Yuan Y Neurol India; 2014; 62(1):68-70. PubMed ID: 24608460 [No Abstract] [Full Text] [Related]
8. Treatment of vascular diseases with Mydocalm. Sztankay C Ther Hung; 1970; 18(3):121-4. PubMed ID: 5496813 [No Abstract] [Full Text] [Related]
9. Response to eperisone in patients of therapy-resistant dissociative convulsions: A report of two cases. Jha VN; Singh PK Indian J Pharmacol; 2017; 49(1):121-123. PubMed ID: 28458436 [TBL] [Abstract][Full Text] [Related]
10. [The effect of myocalm on the hemodynamics of peripheral and kidney circulation in subjects with healthy blood vessels and in patients with obliterative arterial vascular diseases]. Hackel F Z Gesamte Inn Med; 1966 Jul; 21(14):435-9. PubMed ID: 5992292 [No Abstract] [Full Text] [Related]
11. [Muscular diseases and the use of muscle relaxants]. Cunitz G Klin Anasthesiol Intensivther; 1980; 22():252-67. PubMed ID: 7003226 [No Abstract] [Full Text] [Related]
12. [Clinical use of "Muscarum" in temporomandibular joint syndrome]. Shirakawa M; Uzawa S; Shizume M; Wade H; Nakajima T Shikai Tenbo; 1979; 53(3):517-20. PubMed ID: 295974 [No Abstract] [Full Text] [Related]
13. [Clinical application of eperisone hydrochloride to neurogenic bladder]. Murayama K; Katsumi T; Tajika E; Nakamura T Hinyokika Kiyo; 1984 Mar; 30(3):403-8. PubMed ID: 6464913 [TBL] [Abstract][Full Text] [Related]
14. [No sodium--no pain. New guidelines in bone and muscle pain]. Bastigkeit M MMW Fortschr Med; 2000 Mar; 142(13):50-1. PubMed ID: 10783627 [No Abstract] [Full Text] [Related]
15. [Quantitative blood flow of the calf in arterial occlusive diseases of the combined and femoral type during intravenous and intra-arterial administration of Mydocalm]. Hackel F Z Gesamte Inn Med; 1968 Feb; 23(4):109-17. PubMed ID: 5686874 [No Abstract] [Full Text] [Related]
16. [Experience in the use of a new Soviet myorelaxant, dioxonium, in anesthesiology]. Vanevskiĭ VL; Kargapolov LN Vestn Khir Im I I Grek; 1970 Jun; 104(6):74-7. PubMed ID: 5489216 [No Abstract] [Full Text] [Related]
17. Vigabatrin in the Landau-Kleffner syndrome. Appleton R; Hughes A; Beirne M; Acomb B Dev Med Child Neurol; 1993 May; 35(5):457-9. PubMed ID: 7684348 [No Abstract] [Full Text] [Related]
18. Principles of pain management II: agents for neuropathic pain. Tully CM; Gannon R Conn Med; 2005; 69(6):335-8. PubMed ID: 16184859 [No Abstract] [Full Text] [Related]
19. [Personal experiences in the use of two new synthetic muscle relaxants, brevatonal and mediatonal, in anesthesia]. VANDECASTEELE J; LADA T Lille Chir; 1954; 9(2):78-83. PubMed ID: 13175587 [No Abstract] [Full Text] [Related]
20. The effect of the aminoketone nioben in essential circulatory hyperkinesis. Szám I; Büky P Ther Hung; 1976; 24(1):17-9. PubMed ID: 982333 [No Abstract] [Full Text] [Related] [Next] [New Search]